STOCK TITAN

SunOpta, Inc. Form 4 Filings

STKL NASDAQ

Every Form 4 that SunOpta, Inc. (STKL) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow STKL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full STKL filings page.

Rhea-AI Summary

SunOpta Inc. director Diego Reynoso received a grant of 3,834 common shares on February 9, 2026. The shares were issued at $6.39 per share in lieu of cash for service on the board of directors, bringing his direct holdings to 59,372 shares.

Rhea-AI Summary

SunOpta Inc. director David J. Lemmon received a grant of 1,203 common shares on February 9, 2026 as board compensation. The shares were issued in lieu of cash for his service on the board of directors at a stated value of $6.39 per share.

Following this award, Lemmon directly beneficially owns 6,494 SunOpta common shares. This is a routine equity-based compensation transaction classified as a grant, award, or other acquisition rather than an open-market purchase.

Rhea-AI Summary

SunOpta Inc. director Hollis Richard Dean acquired 3,248 common shares of SunOpta on February 9, 2026, at a reported price of $6.39 per share. The shares were issued in lieu of cash for his service on the board of directors.

Following this stock award, Dean directly holds 586,665 SunOpta common shares.

Rhea-AI Summary

SunOpta Inc. director Rebecca Fisher reported receiving 1,760 common shares of SunOpta on February 9, 2026. The shares were issued at $6.39 per share in lieu of cash compensation for her service on the board of directors.

After this equity award, Fisher directly beneficially owns 141,672 common shares of SunOpta. This transaction is reported as an acquisition under a grant, award, or other form of share issuance rather than an open-market purchase.

Rhea-AI Summary

SunOpta Inc. director Albert D. Bolles reported receiving 1,662 common shares on February 9, 2026 at $6.39 per share. The filing shows this was a grant issued in lieu of cash for his service on the board of directors, rather than an open-market purchase.

After this award, Bolles directly beneficially owns 231,646 SunOpta common shares. The transaction is classified as a grant, award, or other acquisition under insider reporting rules, reflecting the company’s practice of compensating directors partly with equity instead of cash.

Rhea-AI Summary

SunOpta Inc. reported that its Chief Human Resources Officer, Danielle Marie Duzan, acquired 22,251 Restricted Stock Units on February 9, 2026. Each unit represents a contingent right to receive one share of STKL common stock.

The RSUs vest in three equal annual installments beginning on April 11, 2026, conditioned on her continued employment through each vesting date. The filing states that these Restricted Stock Units do not have an expiration date and are held as direct beneficial ownership.

Rhea-AI Summary

SunOpta Inc. executive Jennifer Ann Caro, SVP, Sales, received an equity award of 29,854 restricted stock units (RSUs) on February 9, 2026. Each RSU represents a right to receive one share of STKL common stock, with no expiration date.

The RSUs vest in three equal annual installments beginning on April 11, 2026, contingent on her continued employment through each vesting date. After this grant, she beneficially owns 29,854 derivative securities directly.

Rhea-AI Summary

SunOpta CEO and director Brian W. Kocher reported equity-related transactions on January 2, 2026 involving restricted stock units (RSUs) and common shares of STKL.

Two RSU tranches covering 48,134 and 24,666 units were converted into an equal number of common shares at an exercise price of $0 per share. To cover income tax withholding tied to these vestings, the company withheld and disposed of 17,281 and 7,595 common shares at $3.71 per share, as noted in the footnotes.

After these transactions, Kocher beneficially owned 145,716 common shares directly and 84,000 common shares indirectly through the Brian W Kocher Revocable Trust, as well as 48,135 and 24,667 RSUs that remain outstanding.

Rhea-AI Summary

SunOpta Inc. executive, the SVP of R&D and FSQ, reported equity award activity involving company common shares. On 12/16/2025, 10,000 common shares were acquired upon the vesting and settlement of previously granted restricted stock units, reflected with transaction code "M". On the same date, 4,560 common shares were withheld and disposed of at a price of $3.84 per share to cover income tax withholding obligations, shown with transaction code "F".

After these transactions, the reporting person beneficially owned 51,022 SunOpta common shares directly. The reported restricted stock unit award covered in this filing vested in three equal annual installments beginning on December 16, 2023, and does not have an expiration date.

Rhea-AI Summary

SunOpta Inc. (STKL) reported an insider share purchase by its Chief Financial Officer on a Form 4. On 11/24/2025, the CFO acquired 15,000 common shares of SunOpta at a price of $3.39 per share in an open-market purchase coded as "P". Following this transaction, the reporting person beneficially owned 110,970 common shares, held directly. The shares noted in the filing were purchased in multiple transactions, all at the same price of $3.39.

Rhea-AI Summary

SunOpta (STKL) reported an insider equity transaction by its Chief Financial Officer on 10/23/2025. The filing shows the vesting and settlement of restricted stock units (RSUs) and related tax withholding.

The CFO acquired 28,169 common shares upon RSU vesting (code M), then had 12,846 shares withheld (code F) at $5.8 to satisfy tax obligations. Following these transactions, direct beneficial ownership stood at 95,970 common shares. RSUs vest in three equal annual installments beginning on October 23, 2024, and each RSU equals one share.

Rhea-AI Summary

SunOpta Inc. (STKL) filed a Form 4 reporting an insider share award. On 10/22/2025, a director acquired 79 common shares at $5.88. The filing states the shares were issued in lieu of cash for service on the board of directors.

After this transaction, the reporting person beneficially owned 5,291 common shares, held directly.

Rhea-AI Summary

SunOpta Inc. (STKL) reported an insider transaction on Form 4. A director received 477 common shares on 10/22/2025 at $5.88 per share, issued in lieu of cash for board service. Following the transaction, the director beneficially owned 55,538 shares, held directly.

Rhea-AI Summary

SunOpta Inc. (STKL) reported a director-level insider transaction. On 10/22/2025, the director acquired 79 common shares at $5.88 per share, issued in lieu of cash as compensation for board service. Following the transaction, the director beneficially owns 48,331 shares, held directly. No derivative securities were reported.

Rhea-AI Summary

SunOpta Inc. (STKL) reported an insider transaction by a director. On 10/17/2025, the director acquired 1,310 common shares at $5.68 per share. The filing states the shares were issued in lieu of cash as compensation for service on the board of directors.

After the transaction, the director beneficially owns 5,212 shares, held directly. This is a routine equity compensation event and does not reflect open‑market buying or selling.

Rhea-AI Summary

SunOpta (STKL) reported an insider transaction on a Form 4. A company director acquired 3,529 common shares on 10/17/2025 at $5.68 per share, with the filing noting the shares were issued in lieu of cash for service on the board of directors.

Following this transaction, the reporting person beneficially owns 55,061 shares, held directly. This reflects routine equity compensation rather than an open-market purchase.

Rhea-AI Summary

SunOpta Inc. (STKL) disclosed an insider equity award. A company director reported acquiring 1,521 common shares on 10/17/2025 at a $5.68 share price equivalent. Following this transaction, the director now beneficially owns 48,232 shares, held directly.

The filing states the shares were issued in lieu of cash for service on the board of directors, reflecting non‑cash compensation rather than an open‑market purchase.

Rhea-AI Summary

SunOpta Inc. (STKL) disclosed an insider equity award. A company director acquired 1,913 common shares on 10/17/2025 (transaction code A) at $5.68 per share. The filing states the shares were issued in lieu of cash for service on the board of directors.

Following this transaction, the reporting person beneficially owns 139,912 shares, held directly. This reflects routine equity compensation rather than an open‑market purchase.

Rhea-AI Summary

SunOpta Inc. (STKL) reported a director acquisition on a Form 4. On 10/17/2025, the director acquired 7,355 common shares at $5.68 per share (code A).

The filing states the shares were issued in lieu of cash for service on the board of directors. After this transaction, the director beneficially owned 138,211 shares, held directly.

Rhea-AI Summary

SunOpta Inc. (STKL) reported a director acquisition on Form 4. On 10/17/2025, the director acquired 1,806 common shares at $5.68 per share. The filing states the shares were issued in lieu of cash for service on the board of directors.

Following this transaction, the reporting person beneficially owned 229,984 shares, held directly.

Rhea-AI Summary

SunOpta Inc. (STKL) reported an insider transaction on Form 4. A director acquired 3,529 common shares on 10/17/2025, coded A(1), at a stated price of $5.68 per share. The filing states the shares were issued in lieu of cash for service on the board of directors.

Following this transaction, the reporting person beneficially owns 583,417 shares, held directly. This reflects stock-based compensation rather than an open-market purchase.